GLP-1 agonists are dominating the anti-obesity scene — but hurdles remain to their uptake.
Weight loss drugs: the promise and pitfalls
GLP-1 agonists are dominating the anti-obesity scene — but hurdles remain to their uptake.
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.